Advertisement

Topics

Companies Related to "Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation" [Most Relevant Company Matches] - Page: 20 RSS

06:48 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation" found in our extensive corporate database of over 50,000 company records.

Showing "Visilizumab Prevention Graft versus Host Disease After Allogeneic" Companies 476–500 of 3,300+

Probably Relevant

Janssen Alzheimer Immunotherapy

Alzheimer's disease (AD), the most common form of dementia, is a fatal, degenerative brain disease that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities, such as bathing and eating. As AD progresses, individuals may also experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, delusion...


Profectus BioSciences, Inc.

Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mortality. Since its inception in 2003, the Company’s strategic intent has been to develop and acquire the technologies needed to deliver on that mission within high value mark...

Medtronic

Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 2.5 million patients benefit from Medtronic's technology, used to treat conditions such as heart disease, neurological disorders, and vascular illnesses.


Amarantus BioScience, Inc.

Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson’s disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Co...

Business Accelerator Network for Southeast Michigan

The Business Accelerator Network for Southeast Michigan is new region-wide network for building and retaining new business in southeast Michigan. Composed of the region's four key business accelerators- Ann Arbor SPARK, Automation Alley, Macomb-OU INCubator, and TechTown, the organization will work collaboratively to share best practices, host events focused on addressing issues and goals that imp...

VivoMetrics

At VivoMetrics, we collect and analyze continuous ambulatory physiologic data to enhance pharmaceutical research. Each protocol is a distinct project that can include study design support, project management, provision of LifeShirt garments and electronics, site training and administration, data processing and analysis, database management, biostatistical analysis and manuscript writing. All data ...

Parx Casino Philly Cycling Classic

The Parx Casino Philly Cycling Classic is operated by a community-based non-profit organization formed to organize and host the new world-class professional cycling race in Philadelphia. Joining title sponsor Parx Casino is event Founding Sponsor New Penn Financial, and official sponsors Novo Nordisk, Philadelphia Federal Credit Union, Fuji Bikes, Amstel R...

The Lipoprotein(a) Foundation

Because approximately 63 million Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is: To live in a world where high Lipoprotein(a) is routinely diagnosed, treated and family screened. The mission is to prevent cardiovascular events due to high Lipoprotein(a) by diagnosing this inherited r...

Chronix Biomedical

Chronix Biomedical is pioneering a breakthrough approach to the diagnosis, monitoring and management of a broad range of cancers and other conditions. It has developed proprietary technology that measures and categorizes DNA sequences circulating in the blood that are associated with specific changes in disease and health status. Using advanced genome anal...

Diacrin Incorporated

Diacrin is developing transplantable cells for the treatment of human diseases which are characterized by cell dysfunction or cell death and for which current therapies are either inadequate or nonexistent. Products under development for the treatment of neurological disorders include: NeuroCell(TM)-PD for Parkinson's disease and NeuroCell(TM)-HD for Huntington's dise...

Power3 Medical Products, Inc

Originally formed as a medical device company, Power3 Medical Products, Inc. has since transitioned to an innovative holding company strategically positioned to acquire specialty healthcare and biotechnology assets. On May 18, 2004, Power3 purchased the assets and intellectual properties of ProteEx of The Woodlands, TX. The company was founded in 2000 by two seasoned medical biotechnology veterans...

TissueTech, Inc.

TissueTech, Inc. is a leader in regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal, and wound care markets. The NIH has supported research by TissueTech with more than 25 continuous years of research grants. Since its inception in 2001, over 200,000 human implants have been conducted using the Company’...

M3 Biotechnology, Inc.

M3 Biotechnology is a clinical stage company with a novel platform of disease-modifying regenerative therapies particularly relevant to neurodegenerative diseases, with a focus on Alzheimer’s. M3’s lead asset, NDX-1017, modifies growth factor systems and is advanced as a first-in-class, disease-modifying treatment with the potential to restore lo...

Binary Research International Inc.

Founded in 1997, Binary Research International (BRI) is a provider of cutting-edge software solutions, training and services. With headquarters in Glendale, Wisconsin, BRI also has a branch located in Canterbury, England. BRI was a subsidiary of Binary Research Ltd., the original developer of Ghost, now known as Symantec Ghost. While BRI continues to sell,...

Express Logic, Inc.

Headquartered in San Diego, CA, with field offices in Redditch, UK, and Hanover and Munich, Germany, Express Logic offers the most advanced run-time solutions and development tools for deeply embedded applications, including its popular ThreadX® RTOS, the high-performance NetX™ TCP/IP stack, the FileX® embedded FAT-compatible file system, the US...

Newron Pharmaceuticals S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain. The Company is headquartered in Bresso near Milan, Italy. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patie...

Stylus Metrics

We are a Calgary-based company who specialize in product and custom software development for PDAs. We hope you have found what you're looking for. Thank you for visiting. Our Mission"Supporting evidence based decision making with the right metric for the right job at the right time." BenefitsStylus Metrics PDA data collection software (from RTU History Collection to Patient Information, billi...

ID Biomedical Corporation

ID Biomedical Corporation is developing products in two distinct new areas of disease control: gene-based diagnostic testing and subunit vaccines. ID Biomedical Corporation products in development target some of the most serious, worldwide threats to public health, including drug-resistant bacteria, tuberculosis, group A streptococcal disease, HIV/AIDS and E. coli.

Life Medical Sciences Incorporated

Life Medical Sciences, Inc. is a biomaterials company engaged in the development and commercialization of innovative and cost-effective medical devices for therapeutic applications. During 1998, the Company focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology. The Company intends to apply its platform technology to the ...

JMI Laboratories

Established in 2000 by Ronald N. Jones, MD, JMI Laboratories serve as microbiology specialists in the development of antimicrobials. Our experienced professionals provide diverse and flexible services specialized for your company. From support for a biotechnology or pharmaceutical company in its new drug discovery program to monitoring for the emergence of resistance and providing marketing and p...

Anida Pharma, Inc.

Anida is a biopharmaceutical company developing novel first-in-class therapies to treat Parkinson’s disease, amyotrophic lateral sclerosis (ALS; Lou Gehrig disease), other central nervous system disorders, and hearing loss. Our therapeutic concept is based on activating the body’s own homeostatic mechanisms to regulate inflammation, prevent ...

Protein Design Labs Incorporated

PDL is a leader in the development of humanized monoclonal antibodies for the prevention and treatment of a variety of disease conditions. PDL currently has antibodies under development for autoimmune and inflammatory conditions, transplantation, cancers and viral infections. The Company uses proprietary computer software and other technologies to develop its SMART[TM] humanized antibodies for pot...

GeneMax

GeneMax develops innovative immunotherapies in the fields of oncology and infectious disease. Our patented technology restores or increases antigen processing and antigen specific immune responses. GeneMax has demonstrated preclinical efficacy in animal models of lung cancer and melanoma as well as proof of principle for infectious disease pathogens.GeneMax’s program also includes developing a t...

Neuronascent, Inc

Neuronascent began operations in a fully functional cell culture facility in Maryland. Neuronascent is in the process of developing small-molecule therapeutics for Alzheimer’s disease and depression as the main indications for its “neurogenesis” program. An orally-active, neurogenic agent could promote the formation of new neurons in key areas of the brain, replace damaged neurons, and reduc...

Scarab Genomics, LLC

Scarab Genomics, a Madison, Wisconsin based biotechnology company, was established in 2002 to commercialize the Clean Genome® Multiple Deletion Series (MDS) E. coli that resulted from Dr. Fred Blattner’s first sequencing of E. coli at the University of Wisconsin. Scarab Genomics licensed the patented reduced genome technology from the Wisconsin Alu...


More From BioPortfolio on "Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks